glp 1 drugs canada 3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits GLP-1 Drugs from the Gray
Description
DAlessio, Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction
Even enrollees in some less common Medicare plan types can qualify if they also have a stand-alone Part D plan
Hyperglycemia as a cardiovascular risk factor
There was no increase in serious cardiovascular events during 68 weeks of treatment (including follow-up)
doi:10.1016/j.molmet.2018.09.009
